
Memorial Sloan Kettering Cancer Center researchers have managed to grow organoids derived from human prostate cancer tumors in the laboratory, which could provide a perfect platform to test cancer drugs and personalize cancer treatment. The researchers, whose results were published today in emCell/em, successfully grew six prostate cancer organoids from biopsies of patients with metastatic prostate cancer and a seventh organoid from a patient's circulating ...
Read More
You have just read an article categorized health
titled Ability to Grow Prostate Cancer Organoids Provides Researchers With Precision Medicine Tool to Test New Drugs.
Written by:
editor -
Friday, September 5, 2014
There are currently no comments for "Ability to Grow Prostate Cancer Organoids Provides Researchers With Precision Medicine Tool to Test New Drugs"
Post a Comment